Despite that there is precious little evidence stems are beneficial to acute Covid disease and absolutely no evidence it has any effect at all on long Covid, not even from MSB, which loves spruking a new application or two, we have the hopefuls in a delusional ramp about the certainty that stems will cure long Covid.
No wonder this company has no credibility and no market trust.
RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-82
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.005(0.54%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 91.5¢ | $1.473M | 1.596M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32370 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 60258 | 5 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |